Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Par Formulations

2007 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Manufacturer of generic drugs. The company is engaged in the production of solid oral dosage generic pharmaceuticals for the United States and other regulated markets. The company also provides contract research and development services.

Formerly Known As
Novel Therapeutics, Edict Pharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • New No. 1/58, Pudupakkam Main Road
  • Kelambakkam, 603103
  • India

Par Formulations Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Par Formulations‘s full profile, request access.

Request full access to PitchBook

Par Formulations Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Par Formulations‘s full profile, request access.

Request full access to PitchBook

Par Formulations Executive Team (2)

Name Title Board
Seat
Contact
Info
Jaganathan Jayaseelan President

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »